Literature DB >> 1937278

In vivo response of multi-resistant Plasmodium falciparum infections to mefloquine and its combination with sulfadoxine/pyrimethamine in Cambodia.

M B Denis1, R L Kouznetsov, M Giboda.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1937278

Source DB:  PubMed          Journal:  Folia Parasitol (Praha)        ISSN: 0015-5683            Impact factor:   2.122


× No keyword cloud information.
  4 in total

1.  Countrywide survey shows very high prevalence of Plasmodium falciparum multilocus resistance genotypes in Cambodia.

Authors:  Nimol Khim; Christiane Bouchier; Marie-Thérèse Ekala; Sandra Incardona; Pharath Lim; Eric Legrand; Ronan Jambou; Socheat Doung; Odile Mercereau Puijalon; Thierry Fandeur
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

2.  Focused Screening and Treatment (FSAT): a PCR-based strategy to detect malaria parasite carriers and contain drug resistant P. falciparum, Pailin, Cambodia.

Authors:  Stefan Hoyer; Sokomar Nguon; Saorin Kim; Najibullah Habib; Nimol Khim; Sarorn Sum; Eva-Maria Christophel; Steven Bjorge; Andrew Thomson; Sim Kheng; Nguon Chea; Sovann Yok; Samphornarann Top; Seyha Ros; Uth Sophal; Michelle M Thompson; Steve Mellor; Frédéric Ariey; Benoit Witkowski; Chhiang Yeang; Shunmay Yeung; Socheat Duong; Robert D Newman; Didier Menard
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

3.  In vitro antimalarial drug susceptibility in Thai border areas from 1998-2003.

Authors:  Wanna Chaijaroenkul; Kesara Na Bangchang; Mathirut Mungthin; Stephen A Ward
Journal:  Malar J       Date:  2005-08-02       Impact factor: 2.979

4.  Therapeutic efficacy of fixed dose artesunate-mefloquine for the treatment of acute, uncomplicated Plasmodium falciparum malaria in Kampong Speu, Cambodia.

Authors:  Rithea Leang; Sakun Ros; Socheat Duong; Visweswaran Navaratnam; Pharath Lim; Frédéric Ariey; Jean-René Kiechel; Didier Ménard; Walter R J Taylor
Journal:  Malar J       Date:  2013-09-23       Impact factor: 2.979

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.